Axial Spondyloarthritis Highlights From ACR 2023 Axial Spondyloarthritis Highlights From ACR 2023

Key data on axial spondyloarthritis (axSpA) from ACR 2023 include efficacy of intravenous secukinumab, effect of long-term NSAID use, and referral recommendations for patients with suspected axSpA.Medscape

Source: Medscape Today Headlines - December 6, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news